Risk factors associated with severity of dry eye syndrome in ocular graft-versus-host disease

被引:4
作者
Wang, Jay Ching Chieh [1 ]
Mustafa, Majd [2 ]
Teichman, Joshua C. [3 ]
O'Donnell, Heather [4 ]
Broady, Raewyn [5 ]
Yeung, Sonia N. [4 ]
机构
[1] Univ British Columbian, Fac Med, Vancouver, BC, Canada
[2] McGill Univ, Dept Ophthalmol, Montreal, PQ, Canada
[3] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada
[4] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC, Canada
[5] Univ British Columbia, Dept Med, Bone Marrow Transplant Unit, Vancouver, BC, Canada
来源
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE | 2020年 / 55卷 / 05期
关键词
EPSTEIN-BARR-VIRUS; DIAGNOSIS; MANIFESTATIONS; DNA;
D O I
10.1016/j.jcjo.2020.04.013
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: The aim of this study was to identify risk factors for the development of severe dry eye syndrome (DES) in patients with ocular graft-versus-host disease (oGVHD). Design: Retrospective Chart Review. Participants: Patients undergoing allogeneic hematopoietic stem cell transplantation at the British Columbia Cancer Agency between 2011 and 2013. Methods: A retrospective chart review of post-transplant patients with oGVHD DES followed at the British Columbia Cancer Agency Bone Marrow Transplant Unit was performed. Patient and donor data were collected. Descriptive and inferential statistics were carried out. Linear, logistic, and ordered logistic regression analyses were carried out. DES severity was graded using the National Institutes of Health criteria. Results: Of the 78 patients studied, 39 (50%) were male. The median age and Schirmer score were 56 years (range 24-71 years) and 14 mm (range 0-25 mm), respectively. A lower Schirmer score (p = 0.0001), severe overall chronic graft-versus-host disease (GVHD) (p < 0.0001), and lung involvement (p = 0.04) were associated with worsening oGVHD DES. Ordered logistic regression analysis revealed characteristics predictive of oGVHD severity. Fourteen patients (17.95%) had severe DES. Compared with those with nonsevere DES, this group was more likely to be male (p = 0.02) and have a lower Schirmer score (p = 0.01), significantly worse overall chronic GVHD (p = 0.002), as well as lung (p = 0.02) and gastrointestinal tract (p = 0.02) involvement. Logistic regression analysis revealed characteristics predictive of severe oGVHD DES. Conclusion: This study identified potential risk factors associated with the development of severe DES in patients with oGVHD.
引用
收藏
页码:366 / 372
页数:7
相关论文
共 24 条
  • [1] Defining the Intensity of Conditioning Regimens: Working Definitions
    Bacigalupo, Andrea
    Ballen, Karen
    Rizzo, Doug
    Giralt, Sergio
    Lazarus, Hillard
    Ho, Vincent
    Apperley, Jane
    Slavin, Shimon
    Pasquini, Marcelo
    Sandmaier, Brenda M.
    Barrett, John
    Blaise, Didier
    Lowski, Robert
    Horowitz, Mary
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (12) : 1628 - 1633
  • [2] Chronic ocular surface disease after allogeneic bone marrow transplantation
    Balaram, M
    Rashid, S
    Dana, R
    [J]. OCULAR SURFACE, 2005, 3 (04) : 203 - 210
  • [3] Pathogenesis and Management of Graft-versus-Host Disease
    Choi, Sung W.
    Levine, John E.
    Ferrara, James L. M.
    [J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2010, 30 (01) : 75 - +
  • [4] Diagnosis and Treatment of Ocular Chronic Graft-Versus-Host Disease: Report From the German-Austrian-Swiss Consensus Conference on Clinical Practice in Chronic GVHD
    Dietrich-Ntoukas, Tina
    Cursiefen, Claus
    Westekemper, Henrike
    Eberwein, Philipp
    Reinhard, Thomas
    Bertz, Hartmut
    Nepp, Johannes
    Lawitschka, Anita
    Heiligenhaus, Arnd
    Seitz, Berthold
    Messmer, Elisabeth M.
    Meyer-ter-Vehn, Tobias
    Basara, Nadezda
    Greinix, Hildegard
    Datiles, Manuel B.
    Lee, Stephanie J.
    Pavletic, Steven Z.
    Wolff, Daniel
    [J]. CORNEA, 2012, 31 (03) : 299 - 310
  • [5] Graft-versus-host disease
    Ferrara, James L. M.
    Levine, John E.
    Reddy, Pavan
    Holler, Ernst
    [J]. LANCET, 2009, 373 (9674) : 1550 - 1561
  • [6] National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
    Filipovich, AH
    Weisdorf, D
    Pavletic, S
    Socie, G
    Wingard, JR
    Lee, SJ
    Martin, P
    Chien, J
    Przepiorka, D
    Couriel, D
    Cowen, EW
    Dinndorf, P
    Farrell, A
    Hartzman, R
    Henslee-Downey, J
    Jacobsohn, D
    McDonald, G
    Mittleman, B
    Rizzo, JD
    Robinson, M
    Schubert, M
    Schultz, K
    Shulman, H
    Turner, M
    Vogelsang, G
    Flowers, MED
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (12) : 945 - 956
  • [7] Diagnosis and manifestations of chronic graft-versus-host disease
    Filipovich, Alexandra H.
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (02) : 251 - 257
  • [8] FOX RI, 1986, J IMMUNOL, V137, P3162
  • [9] FOX RI, 1992, J RHEUMATOL, V19, P18
  • [10] FOX RI, 1991, SPRINGER SEMIN IMMUN, V13, P217